Hologic, Inc.

NASDAQ:HOLX   4:00:00 PM EDT
79.77
-0.79 (-0.98%)
7:48:52 PM EDT: $80.28 +0.51 (+0.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.53B
Current PE26.41
Forward PE 19.55
2yr Forward PE 18.17
See more stats
Estimates Current Quarter
Revenue$978.95 Million
Adjusted EPS$1.01
See more estimates
10-Day MA$80.58
50-Day MA$81.19
200-Day MA$76.29
See more pivots

Hologic, Inc. Stock, NASDAQ:HOLX

250 Campus Drive, Marlborough, Massachusetts 01752
United States of America
Phone: +1.508.263.2900
Number of Employees: 6990

Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women�s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.